Patent Oppositions in form specific drugs industry

Explore the competitive field of form specific drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in form specific drugs technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the form specific drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the form specific drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Mar 26, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
New Use Of A Combination Of Sacubitril And ValsartanNOVARTISFeb 16, 2026ALFRED E TIEFENBACHER
Liquid Composition Comprising Vegf AntagonistSAMSUNG BIOEPISFeb 16, 2026KILBURN & STRODE
New Use Of A Combination Of Sacubitril And ValsartanNOVARTISFeb 13, 2026ZENTIVA KS
Liquid Composition Comprising Vegf AntagonistSAMSUNG BIOEPISFeb 13, 2026KIVIAL
New Use Of A Combination Of Sacubitril And ValsartanNOVARTISFeb 12, 2026GENERICS UK
Liquid Composition Comprising Vegf AntagonistSAMSUNG BIOEPISFeb 12, 2026MAIWALD
New Use Of A Combination Of Sacubitril And ValsartanNOVARTISFeb 10, 2026LANYON OPPOSITIONS
Empagliflozin For Use In Treating Alport SyndromeGEORG AUGUST UNIVERSITAET GOETTINGEN STIFTUNG OEFFENTLICHEN RECHTSFeb 6, 2026GENERICS UK
Methods Of Treatment Of Cholestatic DiseasesGENFITJan 30, 2026GENERICS UK
Pharmaceutical Composition Containing 2-{4-[N-(5,6-Diphenylpyrazin-2-Yl)-N-Isopropylamino]Butyloxy}-N-(Methylsulfonyl)AcetamideNIPPON SHINYAKUJan 30, 2026PRZYLUSKI

To stay ahead in the competitive form specific drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the form specific drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Mar 26, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM19
Nov 13, 2019Apixaban FormulationsBRISTOL MYERS SQUIBB IRELAND UNLIMITED12
Aug 18, 2021Formulations Of EnzalutamideMEDIVATION PROSTATE THERAPEUTICS12
Dec 11, 2019Rapid Dissolution Formulation Of A Cinacalcet HclAMGEN12
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneEURO CELTIQUE11
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneMUNDIPHARMA11
Dec 5, 2018Apixaban FormulationsPFIZER10
Dec 11, 2019Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor AgonistNOVARTIS10
Oct 16, 2019Apixaban FormulationsBRISTOL MYERS SQUIBB IRELAND UNLIMITED10
Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNA10